Eton Pharmaceuticals (ETON) Tax Provisions (2022 - 2026)

Eton Pharmaceuticals has disclosed Tax Provisions across 5 years of filings, most recently posting $140000.0 for Q2 2026.

• In Q2 2026, Tax Provisions rose 112.12% year-over-year to $140000.0; the TTM figure through Jun 2026 stood at -$891000.0 (down 199.0% YoY), while the FY2025 annual figure was -$957000.0, down 217.57% from the prior year.
• Tax Provisions came in at $140000.0 for Q2 2026 at Eton Pharmaceuticals, up from -$1.1 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $886000.0 in Q4 2024 to a low of -$1.9 million in Q4 2022.
• Average Tax Provisions over 5 years is -$165000.0, with a median of $60000.0 recorded in 2024.
• Year-over-year, Tax Provisions soared 258.7% in 2024 and slumped 220.65% in 2025.
• Over 5 years, Tax Provisions stood at -$1.9 million in 2022, then surged by 113.04% to $247000.0 in 2023, then soared by 258.7% to $886000.0 in 2024, then tumbled by 220.65% to -$1.1 million in 2025, then surged by 113.1% to $140000.0 in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were $140000.0 in Q2 2026, -$1.1 million in Q4 2025, and -$28000.0 in Q3 2025.